Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT04692467
Eligibility Criteria:
Inclusion Criteria:
* PLWH 18-65 years of age
* ART duration ≥ 1 year, stable regimen ≥ 6 months
* HIV 1-RNA \< 1,000 copies/mL within past 12 months
* Pre-HTN (SBP 120-139 or DBP 80-89 mm Hg)
* No current antihypertensive treatment
* Receives HIV care at GHESKIO
* Willing to provide consent
Exclusion Criteria:
* Pregnancy
* Kidney disease or diabetes
* On protease inhibitor/ritonavir
* Advanced illness with limited life expectancy
* Plans to move out of the area within the next year
* Clinician determination that patient is unstable on ART
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT04692467
Study Brief:
Protocol Section:
NCT04692467